Search Details

Word: braine (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...It’s really hard to separate out your academic and residential life,” Gross says. “It’s reasonable and wise to treat the students as students and not as, ‘This half of the brain here; this half of the brain there...

Author: By Katharine A. Kaplan and Rebecca D. O’brien, CRIMSON STAFF WRITERS | Title: Gross Finds Post Overwhelming | 6/10/2004 | See Source »

...president, whom many voters continue to deem decisive and trustworthy. But Bush’s excellent campaign staff—including spin maestro Karl Rove and the likable Texas twang of Karen Hughes—is another big Bush asset. The president’s own Texas-tinted brain trust has already demonstrated its willingness to exploit the tragedy of September 11, 2001 in the campaign’s first round of ads, which prominently feature footage of the World Trade Center’s rubble. Bush may well manage to scare enough Americans into voting for him using these...

Author: By The Crimson Staff, | Title: Beating Bush | 6/9/2004 | See Source »

Scientists at Regeneron, based in New York, are tapping into the same feeding hub in the brain but through a different protein that is more closely related to leptin. Regeneron's agent, Axokine, fools the brain into thinking that the body's fat stores are well stocked, short-circuiting the need to eat. People who took Axokine and stayed on a low-calorie diet and exercise program lost twice as much weight as those who relied on diet and exercise alone...

Author: /time Magazine | Title: America's Obesity Crisis:Pills in the Pipeline | 6/7/2004 | See Source »

...Pfizer, researchers have stumbled upon an agent that curbs the brain's attraction to fatty foods--but so far, only in mice. More studies will show if the same effect occurs in people...

Author: /time Magazine | Title: America's Obesity Crisis:Pills in the Pipeline | 6/7/2004 | See Source »

Even more exciting is a compound that appears to attack obesity through both the brain and the gut. Called rimonabant, and developed by Paris-based Sanofi, it is entering the final stages of human testing. Like Axokine and leptin, rimonabant was designed to make the body feel full. But scientists were pleasantly surprised to find that it also lowered triglyceride levels 15% and raised good cholesterol 22%--far more than would have been expected from weight loss alone. There is also evidence that patients on rimonabant may become more sensitive to the action of insulin, which can halt the progression...

Author: /time Magazine | Title: America's Obesity Crisis:Pills in the Pipeline | 6/7/2004 | See Source »

Previous | 521 | 522 | 523 | 524 | 525 | 526 | 527 | 528 | 529 | 530 | 531 | 532 | 533 | 534 | 535 | 536 | 537 | 538 | 539 | 540 | 541 | Next